This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (40)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Prognostic Factors and Results of Therapy

Ricardo L. Rossi, MD; Blake Cady, MD; Mark L. Silverman, MD; Marvin S. Wool, MD; Stephen G. ReMine, MD; Mary Beth Hodge, MD; Ferdinand A. Salzman, MD

Arch Surg. 1988;123(5):569-574.

Abstract
• A series of 97 consecutive patients with well-differentiated thyroid carcinoma treated between 1941 and 1970 presented with distant metastatic disease or extensive nonresectable local neck disease or had residual carcinoma after thyroid resection. Men 40 years of age or younger and women 50 years of age or younger were considered at low risk for dying of disease; older patients were considered at high risk for dying of disease. Of 17 patients with distant metastatic carcinoma, 40% of younger patients in the low-risk group and 92% of older patients in the high-risk group died. Of 80 patients with unresectable or residual local neck cancer, only 13% of younger patients but 71% of older patients died. Survival related better to risk group classification as defined by age and sex than to any details of disease presentation or management. Treatment was far more successful in patients in the low-risk group.

(Arch Surg 1988;123:569-574)

Author Affiliations
From the Departments of Surgery (Drs Rossi and ReMine), Anatomic Pathology (Dr Silverman), and Radiotherapy (Dr Salzman), and the Section of Endocrinology (Drs Wool and Hodge), Lahey Clinic Medical Center, Burlington, Mass; and the Department of Surgical Oncology, New England Deaconess Hospital, Boston (Dr Cady).

Footnotes
Accepted for publication Jan 4, 1988.

Read before the Annual Meeting of the New England Surgical Society, Bretton Woods, NH, Sept 11, 1987.

Reprint requests to the Department of Surgery, Lahey Clinic Medical Center, 41 Mall Rd, Burlington, MA 01805 (Dr Rossi).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Levothyroxine Suppression of Thyroglobulin in Patients with Differentiated Thyroid Carcinoma
J. Clin. Endocrinol. Metab. 1999;84:4549-4553.
ABSTRACT | FULL TEXT  

Thyroid Cancer With Concurrent Hyperthyroidism
Chao et al.
Arch Surg 1999;134:130-134.
ABSTRACT | FULL TEXT  

Differentiated Thyroid Cancer: Reexamination of Risk Groups and Outcome of Treatment
Sanders and Cady
Arch Surg 1998;133:419-425.
ABSTRACT | FULL TEXT  

Thyroid Cancer: A Lethal Endocrine Neoplasm
Robbins et al.
ANN INTERN MED 1991;115:133-147.
ABSTRACT